Search for: "Hogan v. State" Results 561 - 567 of 567
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Sep 2017, 9:34 pm by Bernie Burk
  Cobb, who recently resigned his partnership in the prominent Washington-London law firm Hogan Lovells (formerly Hogan & Hartson) to accept the engagement representing the President, reportedly sounded off to Dowd about some recent developments with sufficient enthusiasm to be overheard by a Times reporter who happened to be eating at a table nearby. [read post]
26 Jan 2011, 9:52 am by Rebecca Tushnet
Some studies rely on parents’ reporting; not persuasive v. studies where a doctor confirms that the event occurred. [read post]
19 Jun 2022, 5:05 pm by admin
In a seminal discrimination case, Casteneda v. [read post]
22 May 2012, 5:38 am by INFORRM
It provides a good academic and judicial analysis of the current state of media regulation in Australia. [read post]
16 May 2012, 7:37 am by Rob Robinson
 nyti.ms/LEpZVr (Bryan Burrough) International Companies Be Wary of Privacy Laws Overseas That Prohibit Transfer of Personal Data into U.S.- bit.ly/JfeaCL (Bellwether) LinkedIn Financial Services Summit: Key Themes - bit.ly/M4QwOF (Tim Walker) Litigation, Regulation Expected To Add To Forensic And Valuation Workload | Journal of Accountancy - bit.ly/JiSZ8m(Ken Tysiac) More States Introduce Legislation Prohibiting Employer Requests for Social Media Passwords… [read post]
9 Nov 2017, 12:37 pm by Bernie Burk
   At the time (last month), Boies publicly described the scope of his engagement, asserting that he would not be representing Weinstein in any litigation against The Weinstein Company (which he also represented), or assisting celebrity trial lawyer Charles Harder (who represented Hulk Hogan in the invasion of privacy case that broke Gawker) in a $50 million libel case Weinstein was threatening against the New York Times for reporting the first wave of harassment and assault… [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]